AMPK activation promotes lipid oxidation and reduces steatosis, whereas ceramide accumulation, especially from saturated fats, impairs AMPK phosphorylation, drives insulin resistance, and contributes to metabolic dysfunction (15, 16). This evidence concerns the gene PRKAA1 and steatosis.